Centerpoint Advisors’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $163K | Hold |
2,360
| – | – | 0.06% | 93 |
|
|
2025
Q1 | $164K | Sell |
2,360
-250
| -10% | -$17.4K | 0.06% | 91 |
|
|
2024
Q4 | $225K | Buy |
2,610
+35
| +1% | +$3.02K | 0.08% | 84 |
|
|
2024
Q3 | $307K | Sell |
2,575
-20
| -0.8% | -$2.38K | 0.11% | 72 |
|
|
2024
Q2 | $370K | Buy |
2,595
+290
| +13% | +$41.3K | 0.13% | 60 |
|
|
2024
Q1 | $296K | Buy |
2,305
+2,000
| +656% | +$257K | 0.11% | 69 |
|
|
2023
Q4 | $32K | Hold |
305
| – | – | 0.01% | 185 |
|
|
2023
Q3 | $28K | Buy |
+305
| New | +$28K | 0.01% | 195 |
|